References

Links to papers

• Enzyme Potentiated Desensitisation (EPD)
  A promising low-dose method of immunotherapy
  Dr Len McEwen BM., BCh., McEwen Laboratories Ltd., 12 Horseshoe Park, Pangbourne, England RG8 7JW
  
  Dr McEwen’s paper provides a brief history of the development of EPD and summarizes the findings of the published double-blind trials conducted to date.  It also considers in more detail some of the scientific research that provides evidence for the mechanism of the treatment.

• White Paper for United States Senators and Representatives
  Enzyme Potentiated Desensitization (EPD), The American EPD Study: 1993-2000
  W.A. Schrader, Jr., M.D. and Randall E. Wilkinson, M.D., September 2001; revised 10.15.01
  
  The above paper summarizes the US data collected while EPD was in use with Investigational Review Board oversight.  Patients reported the progress of symptoms on a subjective basis for all conditions from which they suffered, not only those for which they were being treated with EPD.  The study groups together all patients, whether treated for inhalant allergies alone, food allergies alone, or both.  Although the efficacy data obtained in this way must only be considered suggestive, the paper is evidence of the excellent safety record of EPD in the clinic.